MICHELLE MATLOCK: Open Payments
NPI 1952600801 · SPRINGFIELD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$494 in 21 payments from 11 companies in 2025. Trend: 2023 $17 · 2024 $133 · 2025 $494
Food & beverage: $494
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $167 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $65 |
| Lilly USA, LLC | 3 | $59 |
| ACADIA Pharmaceuticals Inc | 2 | $43 |
| Mallinckrodt Hospital Products Inc. | 1 | $34 |
| Eisai Inc. | 1 | $30 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| Biogen, Inc. | 1 | $21 |
| Amneal Pharmaceuticals LLC | 1 | $20 |
| Abbott Laboratories | 1 | $16 |
Products named: AIRSUPRA, HYQVIA, NUPLAZID, AMYVID, ACTHAR, Leqembi, INGREZZA, VUMERITY.
Industry payments across OH — which companies pay providers there.
